Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of British Columbia

$31,800.00

Regulation of microRNA maturation

FY 2018-19

Summary
Small, non-coding microRNAs (miRNAs) are important in many biological processes by regulating expression of specific target messenger RNAs (mRNAs) through inhibiting translation or inducing mRNA degradation. Approximately 3,000 miRNAs have been identified in the human genome, and each miRNA controls networks of about 10-100 specific target mRNAs affecting approximately 20,000 human genes in total. miRNA biogenesis occurs through five major steps, but the one which is least well characterized is the process by which precursor miRNA (pre-mRNA) undergoes maturation to give the functional, mature miRNA. Our lab has studied the expression of miRNA-155 (miR-155) in immune cells since inappropriate elevation in miR-155 underlies many immune disorders and cancers. We have shown that miR-155 production is rapidly induced by inflammatory stimuli (e.g. the bacterial cell wall component lipopolysaccharide, LPS) in an immune cell type called the macrophage. Addition of the anti-inflammatory cytokine interleukin-10 (IL-10) to LPS-stimulated cells reduces miR-155 levels by inhibiting of the maturation of pre-miR-155 to miR-155. However, the mechanism by which IL-10 inhibits the maturation of pre-miR-155 to miR-155 is still unknown. We HYPOTHESIZE that IL-10 inhibits the maturation of pre-miR-155 through regulating proteins that bind to miR-155, and this mode of regulation applies to other miRNAs regulated by IL-10. Our goals are: 1) to identify proteins which bind to pre-miR-155 in cells stimulated with LPS with or without IL-10, and 2) to determine their roles in pre-miR-155 maturation. We expect to find either changes to the identity of the proteins associated with pre-miR-155 or changes in post-translational modifications (e.g. phosphorylation) of these proteins in response to LPS +/- IL-10. We will subsequently extend these findings to other miRNAs whose levels are altered by LPS and/or IL-10. These studies will provide important insight into the regulation of an important class of regulatory RNAs.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2014-05662
Name nom
Mui, Alice
Department département
Surgery - Surgery
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2014
Award amount
31800
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5402
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Nucleic acids
Research subject fr
Acides nucléiques
Partie
5
Nb partie
5
Application title
Regulation of microRNA maturation
Keyword
NSERC
Application summary
Small, non-coding microRNAs (miRNAs) are important in many biological processes by regulating expression of specific target messenger RNAs (mRNAs) through inhibiting translation or inducing mRNA degradation. Approximately 3,000 miRNAs have been identified in the human genome, and each miRNA controls networks of about 10-100 specific target mRNAs affecting approximately 20,000 human genes in total. miRNA biogenesis occurs through five major steps, but the one which is least well characterized is the process by which precursor miRNA (pre-mRNA) undergoes maturation to give the functional, mature miRNA. Our lab has studied the expression of miRNA-155 (miR-155) in immune cells since inappropriate elevation in miR-155 underlies many immune disorders and cancers. We have shown that miR-155 production is rapidly induced by inflammatory stimuli (e.g. the bacterial cell wall component lipopolysaccharide, LPS) in an immune cell type called the macrophage. Addition of the anti-inflammatory cytokine interleukin-10 (IL-10) to LPS-stimulated cells reduces miR-155 levels by inhibiting of the maturation of pre-miR-155 to miR-155. However, the mechanism by which IL-10 inhibits the maturation of pre-miR-155 to miR-155 is still unknown. We HYPOTHESIZE that IL-10 inhibits the maturation of pre-miR-155 through regulating proteins that bind to miR-155, and this mode of regulation applies to other miRNAs regulated by IL-10. Our goals are: 1) to identify proteins which bind to pre-miR-155 in cells stimulated with LPS with or without IL-10, and 2) to determine their roles in pre-miR-155 maturation. We expect to find either changes to the identity of the proteins associated with pre-miR-155 or changes in post-translational modifications (e.g. phosphorylation) of these proteins in response to LPS +/- IL-10. We will subsequently extend these findings to other miRNAs whose levels are altered by LPS and/or IL-10. These studies will provide important insight into the regulation of an important class of regulatory RNAs.